Suven Life Sciences Ltd
SUVENSuven Life Sciences Ltd
SUVEN
Price Chart
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -15.88 | 4.89 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 44.56 | 5.12 | 0.70% |
Forecast & Ratings
Detailed ForecastPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Suven Life Sciences Limited is a bio-pharmaceutical company, engaged in the business of manufacture and sale of bulk drugs and intermediaries.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Dr Reddy's Laboratories Ltd
Mankind Pharma Ltd
Torrent Pharmaceuticals Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 529.44 | 518.81 | 564.62 | 648.53 | 312.92 | 28.45 | 21.23 | 17.16 | 27.99 | 38.52 | ||||||||||
Raw Materials | 177.25 | 178.45 | 154.81 | 176.16 | 79.62 | 0.00 | 0.00 | 0.00 | 0.00 | 147.10 | ||||||||||
| Power & Fuel Cost | 28.04 | 29.32 | 31.50 | 33.56 | 19.37 | 1.63 | 0.00 | 0.00 | 0.00 | |||||||||||
| Employee Cost | 36.51 | 40.94 | 52.17 | 61.27 | 36.49 | 17.41 | 18.53 | 21.02 | 18.62 | |||||||||||
| Selling & Administrative Expenses | 74.42 | 113.67 | 124.44 | 117.18 | 136.02 | 107.88 | 73.85 | 109.14 | 118.30 | |||||||||||
| Operating & Other expenses | 45.18 | 35.48 | 51.54 | 38.89 | 28.56 | 3.21 | 1.04 | 3.93 | 2.26 | |||||||||||
EBITDA | 168.04 | 120.95 | 150.16 | 221.47 | 12.86 | -101.68 | -72.19 | -116.93 | -111.19 | -108.58 | ||||||||||
| Depreciation/Amortization | 11.78 | 17.50 | 21.41 | 21.31 | 10.79 | 4.17 | 4.35 | 4.39 | 6.54 | 6.73 | ||||||||||
| PBIT | 156.26 | 103.45 | 128.75 | 200.16 | 2.07 | -105.85 | -76.54 | -121.32 | -117.73 | -115.31 | ||||||||||
| Interest & Other Items | 4.71 | 5.88 | 5.68 | 4.63 | 1.91 | 0.55 | 0.94 | 0.67 | 0.54 | 0.20 | ||||||||||
| PBT | 151.55 | 97.57 | 123.07 | 195.53 | 0.16 | -106.40 | -77.48 | -121.99 | -118.27 | -115.51 | ||||||||||
| Taxes & Other Items | 42.81 | 25.73 | 35.88 | 71.84 | 24.06 | -12.18 | -5.32 | 0.00 | 0.00 | — | ||||||||||
| Net Income | 108.74 | 71.84 | 87.19 | 123.69 | -23.90 | -94.22 | -72.16 | -121.99 | -118.27 | -115.51 | ||||||||||
| EPS | 0.43 | 0.26 | 0.32 | 0.45 | -0.09 | -0.65 | -5.22 | -8.25 | -6.29 | -5.30 | ||||||||||
| DPS | 0.03 | 0.09 | 0.05 | 0.07 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.06 | 0.35 | 0.15 | 0.15 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Investor Presentation
Annual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Suven Life Sciences Ltd | -15.51 | 4.89 | — |
| Sun Pharmaceutical Industries Ltd | 35.10 | 5.01 | 0.93% |
| Cipla Ltd | 35.28 | 4.17 | 0.69% |
| Dr Reddy's Laboratories Ltd | 21.34 | 4.13 | 0.69% |
Price Comparison
Compare SUVEN with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Increased Total Retail Holding
In last 3 months, retail holding in the company has increased by 1.07%
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateFeb 17, 2021
Dividend/Share
₹1.00
Ex DateEx Date
Feb 17, 2021
Cash Dividend
Ex DateEx DateFeb 14, 2019
Dividend/Share
₹1.50
Ex DateEx Date
Feb 14, 2019
Cash Dividend
Ex DateEx DateFeb 6, 2018
Dividend/Share
₹1.50
Ex DateEx Date
Feb 6, 2018
Cash Dividend
Ex DateEx DateFeb 8, 2017
Dividend/Share
₹1.00
Ex DateEx Date
Feb 8, 2017
Cash Dividend
Ex DateEx DateMar 14, 2016
Dividend/Share
₹1.00
Ex DateEx Date
Mar 14, 2016
News & Opinions
News Video
Suven Life Sciences' Venkat Jasti Speaks On Weak Q4 Results & Suven Neuro Listing Plans | CNBC-TV18
6 months ago•CNBC-TV18
Q4 Review | Suven Life Sciences’ Q4 Report Card & FY24 Projections
6 months ago•Bloomberg Quint
News Video
Q4 Review | Suven Life Sciences’ Q4 Report Card & FY24 Projections | BQ Prime
6 months ago•BQ Prime
Suven Life Sciences breathes new life into drug discovery plans
8 months ago•Economic Times
RIL-backed co, new-age techies among 41 firms to post losses for 4 straight quarters
9 months ago•Economic Times
Advent closes in on Suven Pharma buyout
11 months ago•Economic Times
Tech Query: Is the trend in Tech Mahindra reversing?
1 year ago•The Hindu Businessline
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of -46.66%, vs industry avg of 8.45%
Decreasing Market Share
Over the last 5 years, market share decreased from 0.32% to 0.01%